Cian Healthcare Limited (BOM:542678)
India · Delayed Price · Currency is INR 13.39
+0.63 (4.94%)
At close: Sep 4, 2026
Cian Healthcare Revenue
In the fiscal year ending March 31, 2026, Cian Healthcare had annual revenue of 294.69M INR, down -4.49%. Cian Healthcare had revenue of 113.22M in the half year ending September 30, 2025, a decrease of -65.28%.
Revenue
294.69M
Revenue Growth
-5.14%
P/S Ratio
1.14
Revenue / Employee
n/a
Employees
185
Market Cap
334.75M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 294.69M | -13.85M | -4.49% |
| Mar 31, 2025 | 308.54M | -310.38M | -50.15% |
| Mar 31, 2024 | 618.92M | -67.84M | -9.88% |
| Mar 31, 2023 | 686.76M | -93.90M | -12.03% |
| Mar 31, 2022 | 780.66M | 41.25M | 5.58% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Murae Organisor | 8.59B |
| Welcure Drugs and Pharmaceuticals | 3.66B |
| Rajnish Wellness | 1.68B |
| JFL Life Sciences | 1.31B |
| ANG Lifesciences India | 862.13M |
| Deccan Health Care | 818.34M |
| Sandu Pharmaceuticals | 696.24M |
| Panjon | 492.78M |